Delivery Order SPE2DB22D2108-SPE2DB24FU2ZY
- Not listed
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NASCOBAL 500 MCG NASAL SPRAYS. The $4,092.06 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has a completion date of March 1, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a ceiling value of $1,580.56 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The award, valued at $4,784.42, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $12,827.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS, a specialized pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of July 25, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,710.28 Firm Fixed Price Delivery Order is for the supply of 4554939940 NASCOBAL 500 MCG NASAL SPRAYS. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,943.89 firm fixed-price delivery order is for the supply of NASCOBAL 500 MCG nasal sprays. The award was made under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $1,733.87 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 12, 2022 and was awarded on April 11, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,600.70 firm fixed-price contract is for the supply of NASCOBAL 500 MCG nasal sprays. The contract has a period of performance through March 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,170.35 firm fixed-price delivery order is for the supply of NASCOBAL 500 MCG NASAL SPRAYS. The award has an ultimate completion date of August 9, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,300.32 firm fixed-price contract is for the delivery of 4559909224 NASCOBAL 500 MCG nasal sprays, with a completion date of February 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU2ZYDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,338.26, is for the supply of NASCOBAL 500 MCG NASAL SPRAYS to support military healthcare programs. As an open competition contract with no set-aside designation, Amerisourcebergen was selected to provide these critical pharmaceutical products to the DLA. The company's extensive experience and capabilities in supplying a comprehensive range of medical commodities to federal agencies, particularly the DLA, make it a key vendor for these types of contracts. This award is part of Amerisourcebergen's broader $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide array of pharmaceutical and medical supplies to support military healthcare needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/2/24 |